Disease relevance of Desensitization, Immunologic

• Lowell and Franklin on double-blind hyposensitization therapy for ragweed hay fever: the paper [1].

High impact information on Desensitization, Immunologic

• Lowell and Franklin on double-blind hyposensitization therapy for ragweed hay fever: the people [2].
• BACKGROUND: Determination of the allergen composition of an extract is essential for the improvement of hyposensitization therapy [3].
• OBJECTIVE: A patient whose allergic rhinitis (AR) resolved after allergen immunotherapy (AIT) but recurred after the patient received an autologous BMT is reported [4].
• During hyposensitization therapy with aluminium-precipitated antigen solutions, a small % of patients develop persistent subcutaneous nodules at the injection site; the existence of delayed sensitivity to aluminium has been implicated in the pathogenesis of these nodules [5].
• An active component, BWD II 22-3, might prove effective in the hyposensitization therapy of buckwheat-sensitive patients [6].

Chemical compound and disease context of Desensitization, Immunologic

• The effect of Disodium cromoglycate (Lomudal, Intal) on allergic rhinitis, given as a solution in a nasal spray, was studied in 23 adult volunteers with grass pollen allergy, none of whom were having hyposensitization therapy [7].

Anatomical context of Desensitization, Immunologic

• Frequency estimations of allergen-reactive T cells before, during and after the completion of hyposensitization therapy might help to clarify their possible role in the allergic symptoms [8].

Associations of Desensitization, Immunologic with chemical compounds

• It is suggested that EACA can be used to increase the stability of aqueous allergen extracts for skin testing and for hyposensitization therapy [9].
• 13 of them had pruritic excoriated papules, 9 at sites of hyposensitization therapy with aluminium-bound pollen extracts, and 4 at sites of childhood immunization with an aluminium-bound vaccine (Di-Te-Pol) [10].
• Polymerization using glutaraldehyde markedly improved the apparently low efficacy of an asthma-inducing sea squirt antigen, DIIa (MW 9,980), in hyposensitization therapy on patients with sea squirt allergy [11].
• Hyposensitization therapy with alum-precipitated pyridine extracts in animal dander sensitive patients [12].
• 2) The therapy with menaquinone, in conjunction with hyposensitization therapy, gave an effective rate of 100% (a markedly effective rate of 33.3%) [13].

Gene context of Desensitization, Immunologic

• Hyposensitization therapy with APP extracts was found to be effective in 80% of 185 patients allergic to animals (96 to cats, 84 to dogs and 5 to horses) with a minimum of reactions (2.5 local and 0.2% constitutional) [12].

References